Malya Sahu, MD

MS Fellow @HopkinsMedicine | Prev @Fogarty_NIH @PennNeurology @JeffersonUniv | Interested in MS, global neurology, health equity | she/her | Tweets are my own

[Neurology: Clinical Practice @NeurologyCP]

This study assessed global access to paraclinical testing incorporated in MS diagnostic criteria. Read more: https://t.co/5FNmRnqjaI

[Malya Sahu, MD @MSahuMD]

Exciting conversation on our team’s work examining barriers to diagnosis for MS in Africa - reminds us that absence of data is not absence of disease #AFRICTRIMS @DuoduFiifi @DeannaSaylor1 @mashina_chomba

[Neurology Journal @GreenJournal]

In this episode of the Neurology Podcast: Drs. Paul Crane, Fiifi Duodu, and Malya Sahu discuss neuroimmunology and #MultipleSclerosis diagnosis in Africa, including challenges and efforts to improve care. Listen now: https://t.co/dORavIW94W

#GlobalNeurology @MSahuMD

[Malya Sahu, MD @MSahuMD]

Inaugural Reciprocal Innovation Workshop: Impactful Solutions to Today’s Health Challenges May Emerge from Unexpected Places

https://t.co/nhJdEQJciY

[NEJM @NEJM]

This video in our partnership with @DGlaucomflecken explains a head-to-head trial comparing rituximab versus ocrelizumab in newly diagnosed relapsing multiple sclerosis. Access the full results of the OVERLORD-MS trial for free: https://t.co/svECoPL5GZ

#neurology

[Malya Sahu, MD @MSahuMD]

AQP4+ NMOSD carries a high mortality, especially in resource-limited settings. We report on a cohort in Zambia (4/10 died within 1 year on symptom onset) and discuss contributing factors and proposed solutions.
https://t.co/gPAt0SYDbw

[The Sumaira Foundation @TheSumairaFDN]

🇬🇭 We're coming to Ghana!

We're partnering with The Nerve of My MS for the 1st AFRICTRIMS Patient Day on May 29th in Accra.
If you're a patient, caregiver or clinician impacted by or working in #MS, #NMOSD or #MOGAD, join us!

To register, visit https://t.co/TmGpvPBplZ

[National MS Society @mssociety]

In a disease like MS that so disproportionately affects women, female voices in research aren’t just important — they’re essential.

This Women's History Month, we're celebrating the women scientists changing the landscape of MS research and mentorship for future leaders.

[MSJ @MSJ_Research]

Diagnostic pathways and barriers in #MultipleSclerosis in Zambia: Misinterpretation of symptoms, lack of specialists, and systemic health system limitations.

🔓MSJ-ETC study from @mashina_chomba @UnzaOfficial @DeannaSaylor1 @UNC ▶️ https://t.co/6YF0eqGQN2

[MS Int'l Federation @MSIntFederation]

📢 A recently published study — The Current State of Diagnostics for Neuroimmunological Conditions in Africa — sheds light on the realities of MS diagnosis across the continent. Read the full article 👉 https://t.co/0DmFDR92Qy

[The Sumaira Foundation @TheSumairaFDN]

"The Current State of Diagnostics for Neuroimmunological Disorders in Africa"

Important & insightful paper published in the Journal of Central Nervous System Disease by @MSahuMD, Mashina Chomba, Fiifi Duodu, Monica Diaz, Dilraj Sokhi & @DeannaSaylor1

https://t.co/RrtTiY9ghE

[MS Int'l Federation @MSIntFederation]

🌍 MS around the world: diagnostic & treatment challenges at #ECTRIMS2025

💊 Dr Deanna Saylor shared how getting MS therapies on the WHO Essential Medicines List is a milestone for global access. The session was Co-chaired by Dr Bassem Yamout.

👉 https://t.co/lbM34DsXHa

[International Women in MS #iWiMS @IntNatlWiMS]

At #ECTRIMS2025?
Join the #iWiMS reception to hear from our international panel @darshi_r @EthelScl Noriko Isobe JackiePalace Antje Bischof Malya Sahu & Sibongile Tito, and welcome @KristenKryskoMD, #RachelHornePrize winner 2025!
Hilton Diagonal Mar
Ballroom A1+A2 at 6:30pm

[MSJ @MSJ_Research]

Black African people born and evaluated in Zambia experienced prolonged #MultipleSclerosis diagnostic delays when compared to non-black Zambians born and/or evaluated outside Zambia.

Study from @DeannaSaylor1 @UnzaOfficial @UniversityofNo7 ▶️https://t.co/xylMjI6pxG

[Malya Sahu, MD @MSahuMD]

Excited to share this important work on delays to diagnosis of MS in Zambia that underscores the need for improved awareness, especially amongst HCWs @MSJ_Research @DeannaSaylor1
https://t.co/vFnu5eHdlZ

[The Sumaira Foundation @TheSumairaFDN]

TSF presents "NMOSD in Sub-Saharan Africa"

Join us on March 17th to hear from experts from Ghana 🇬🇭, Kenya 🇰🇪, South Africa 🇿🇦 & Zambia 🇿🇲 to discuss the incidence of #NMOSD, diagnostics, treatments, immunizations, clinical trials and more.

Register: https://t.co/IN3dP2fKeA

[Neurology Journal @GreenJournal]

Learn about the diagnostic potential of dried blood spot sampling for neuromyelitis optica spectrum disorder (NMOSD) in resource-limited settings in this Neurology blog: https://t.co/92N36L8s2F

#GlobalNeurology #NeuroTwitter @MSahuMD

[Malya Sahu, MD @MSahuMD]

I’ve seen nearly a dozen patients with NMOSD in Zambia, many of whom experienced 2+ debilitating attacks before diagnosis. The good news is there is hope! Thank you to @Neurology Without Borders & @DeannaSaylor1 for helping highlight the path ahead

https://t.co/VpT4GeCc7c

[Malya Sahu, MD @MSahuMD]

Excited and honored to be collaborating with brilliant minds to explore the impact of delayed and missed diagnosis, and understand care-seeking behaviors for #MultipleSclerosis #NMOSD here in Zambia 🇿🇲

[American Brain Foundation @ABFbrain]

Meet Dr. Malya Sahu, one of our 2024 Next Generation Research Grant recipients! Dr. Sahu is investigating the prevalence and diagnosis of MS in Zambia, where studies suggest MS is underdiagnosed and undertreated.

Learn about other research we’re funding:
https://t.co/Tt0PtLByIk

[Fogarty at NIH @Fogarty_NIH]

We capped the end of our #Fogarty LAUNCH orientation week with a keynote from Dr. Anthony Fauci. ℹ️ Learn more about our flagship training program now in its 21st year! https://t.co/MPEKga4DnW
#GlobalHealth 🌍🔬🧬

[Malya Sahu, MD @MSahuMD]

And that’s a wrap on residency! 🥹🥳🧠@PennNeurology #ClassOf2024